Länder Analysen: Großbritannien
| 29.07.25 | AstraZeneca Outperform | Bernstein Research | |
| 29.07.25 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 29.07.25 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 29.07.25 | AstraZeneca Buy | UBS AG | |
| 29.07.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 28.07.25 | Diageo Outperform | Bernstein Research | |
| 28.07.25 | National Grid Buy | Jefferies & Company Inc. | |
| 28.07.25 | ASOS Sector Perform | RBC Capital Markets | |
|
Werbung
|
|||
| 28.07.25 | GSK Outperform | Bernstein Research | |
| 28.07.25 | AstraZeneca Outperform | Bernstein Research | |
| 28.07.25 | London Stock Exchange (LSE) Buy | UBS AG | |
| 28.07.25 | RELX Hold | Deutsche Bank AG | |
| 28.07.25 | easyJet Market-Perform | Bernstein Research | |
| 25.07.25 | Rolls-Royce Buy | Deutsche Bank AG | |
| 25.07.25 | Reckitt Benckiser Equal Weight | Barclays Capital | |
| 25.07.25 | RELX Overweight | Barclays Capital | |
| 25.07.25 | RELX Buy | UBS AG | |
| 24.07.25 | Reckitt Benckiser Outperform | RBC Capital Markets | |
| 24.07.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 24.07.25 | RELX Buy | UBS AG | |
| 24.07.25 | Reckitt Benckiser Outperform | Bernstein Research | |
| 24.07.25 | Vodafone Group Underperform | Bernstein Research | |
| 24.07.25 | Vodafone Group Neutral | UBS AG | |
| 24.07.25 | Vodafone Group Underweight | JP Morgan Chase & Co. | |
| 23.07.25 | Rio Tinto Buy | Deutsche Bank AG | |
| 23.07.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 23.07.25 | Rio Tinto Overweight | JP Morgan Chase & Co. | |
| 23.07.25 | HSBC Neutral | JP Morgan Chase & Co. | |
| 22.07.25 | London Stock Exchange (LSE) Outperform | RBC Capital Markets | |
| 22.07.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 22.07.25 | easyJet Market-Perform | Bernstein Research | |
| 22.07.25 | National Grid Overweight | Barclays Capital | |
| 21.07.25 | GSK Underweight | JP Morgan Chase & Co. | |
| 21.07.25 | Linde Outperform | RBC Capital Markets | |
| 21.07.25 | BP Neutral | UBS AG | |
| 21.07.25 | BAT Buy | Deutsche Bank AG | |
| 21.07.25 | BP Neutral | JP Morgan Chase & Co. | |
| 21.07.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 21.07.25 | GSK Neutral | Goldman Sachs Group Inc. | |
| 21.07.25 | Unilever Underperform | RBC Capital Markets | |
| 21.07.25 | Unilever Overweight | Barclays Capital | |
| 21.07.25 | easyJet Outperform | RBC Capital Markets | |
| 21.07.25 | HSBC Neutral | JP Morgan Chase & Co. | |
| 21.07.25 | easyJet Buy | UBS AG | |
| 18.07.25 | easyJet Overweight | Barclays Capital | |
| 18.07.25 | Reckitt Benckiser Outperform | RBC Capital Markets | |
| 18.07.25 | easyJet Hold | Deutsche Bank AG | |
| 18.07.25 | GSK Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 18.07.25 | Rio Tinto Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 18.07.25 | GSK Underweight | JP Morgan Chase & Co. | |